Humanized antibodies are monoclonal antibodies that have been engineered to be more similar to human antibodies. This process, known as humanization, involves modifying the protein sequences of non-human antibodies to match those of human antibodies closely. By doing so, the immune system is less likely to recognize them as foreign, reducing the potential for adverse reactions.
